UPDATE 1-FDA allows Curis to resume testing cancer drug

March 31 (Reuters) - Curis Inc said the U.S. Food and Drug Administration allowed it to resume testing of its experimental cancer drug, lifting a November order halting enrolment in an early-stage...

from Reuters: Hot Stocks http://ift.tt/1ki1X3t